Konstantin Konstantinov

This inventor holds 21 USPTO granted patents and 11 published patent applications, plus 8 CIPO patents and 11 EPO patents, primarily in Biopharmaceutical Manufacturing. Top assignees: Genzyme Corporation, Bayer Healthcare LLC, Bayer Corporation. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Konstantin Konstantinov. Retrieved from https://idiyas.com/inventor/konstantin-konstantinov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 11)

% Patents Active = 100.0

CIPO Patents = 8 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 12)

Average Co-Inventor Count = 4.6

ph-index = 6

Forward Citations = 154(Granted Patents)

Location History:

Walnut Creek, CA (US) (2002 - 2010)
Waban, MA (US) (2015 - 2024)
Bridgewater, NJ (US) (2017 - 2024)

Company Filing History:

Bayer Pharmaceuticals Corporation

Years Active: 2002-2025

Loading Chart...

Areas of Expertise:

Extracellular Vesicles

Therapeutic Proteins

Chromatography

Manufacturing Processes

Disulfide Bonds

Seed Train Processes

Biological Molecules

Mammalian Cells

Cell Culture

Macromolecules

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12357571 - Loading of extracellular vesicles through imparting of mechanical shear (2025-07-15),

2. 12110312 - Integrated continuous manufacturing of therapeutic protein drug substances (2024-10-08),

3. 11912739 - Sterile chromatography and manufacturing processes (2024-02-27),

4. 11884703 - Methods of processing a fluid including a recombinant therapeutic protein and use thereof (2024-01-30),

5. 11839861 - Sterile chromatography resin and use thereof in manufacturing processes (2023-12-12),

6. 10968252 - Methods of processing a fluid including a recombinant therapeutic protein and use thereof (2021-04-06),

7. 10919021 - Sterile chromatography resin and use thereof in manufacturing processes (2021-02-16),

8. 10711034 - Integrated continuous manufacturing of therapeutic protein drug substances (2020-07-14),

9. 10647777 - Methods of controlling the formation of disulfide bonds in protein solutions (2020-05-12),

10. 10570367 - Seed train processes and uses thereof (2020-02-25),

11. 10087214 - Sterile chromatography and manufacturing processes (2018-10-02),

12. 10071364 - Sterile affinity chromatography resin (2018-09-11),

13. 9657056 - Integrated continuous manufacturing of therapeutic protein drug substances (2017-05-23),

14. 9650413 - Integrated continuous manufacturing of therapeutic protein drug substances (2017-05-16),

15. 9650412 - Integrated continuous manufacturing of therapeutic protein drug substances (2017-05-16),

Title: Innovator Profile: Konstantin Konstantinov

Introduction

Konstantin Konstantinov, based in Waban, MA, is a prominent inventor with a total of 19 patents to his name. His contributions to the field of biotechnology, specifically in therapeutic protein drug manufacturing, have established him as a significant figure in innovation and research.

Latest Patents

Among his latest patents, Konstantinov has developed groundbreaking technologies aimed at improving the efficiency and effectiveness of biomanufacturing processes. One of his notable patents is for "Integrated continuous manufacturing of therapeutic protein drug substances," which outlines innovative continuous biomanufacturing processes. These processes allow for the consistent production of therapeutic protein drug substances, enhancing the ability to meet healthcare demands.

Another crucial patent involves "Sterile chromatography and manufacturing processes," detailing methods for conducting chromatography using gamma-irradiated chromatography resin. This patent emphasizes the integration of closed or substantially closed continuous processes for the production of recombinant proteins, where the chromatography resin is systematically exposed to denaturing buffers to ensure high standards of safety and effectiveness in production.

Career Highlights

Konstantinov's impressive career includes significant positions at renowned companies such as Genzyme Corporation and Bayer Healthcare LLC. His work at these organizations has further propelled advancements in biomanufacturing and therapeutic protein development.

Collaborations

Throughout his career, Konstantinov has collaborated with several talented professionals, including Veena Warikoo and Rahul Godawat. These collaborations have enriched his research and propelled forward the innovations in the biotech sector.

Conclusion

Konstantin Konstantinov is a distinguished inventor with a strong portfolio of patents that illustrate his commitment to advancing biomanufacturing processes. His innovative approaches and collaborations reflect his significant contributions to the field, demonstrating the vital role of inventors in shaping the future of therapeutic development.

Profile summary based on public USPTO records.